Octapharma helping to change the paradigm in Portuguese plasma

LACHEN, August 19th 2015: Portugal will receive a continuous flow of blood products from Portuguese ...

Octapharma USA: FDA Approves WILATE® License Supplement – Perioperative Management of Bleeding in Patients with von Willebrand Disease

HOBOKEN, N.J. August 13th, 2015 – Octapharma USA today announced the U.S. Food and Drug Administrati...

Meet us globally

Since its establishment in 1983, Octapharma has grown into a truly global company providing life enhancing therapies to patients in over 100 countries. To find your local Octapharma office, access our global locations map 


Octapharma’s success is the result of the combined contribution of all employees, what we call “the human factor”. To embark on a challenging and rewarding career in an innovative biopharmaceutical organization, explore our global opportunities